Radcliffe Capital Management’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-391,501
| Closed | -$3.9M | – | 1136 |
|
|
2022
Q3 | $3.9M | Buy |
391,501
+52,523
| +15% | +$524K | 0.09% | 374 |
|
|
2022
Q2 | $3.35M | Buy |
338,978
+1,501
| +0.4% | +$14.8K | 0.08% | 447 |
|
|
2022
Q1 | $3.32M | Buy |
337,477
+87,477
| +35% | +$861K | 0.08% | 410 |
|
|
2021
Q4 | $2.44M | Hold |
250,000
| – | – | 0.06% | 482 |
|
|
2021
Q3 | $2.45M | Hold |
250,000
| – | – | 0.07% | 401 |
|
|
2021
Q2 | $2.44M | Hold |
250,000
| – | – | 0.08% | 410 |
|
|
2021
Q1 | $2.49M | Buy |
+250,000
| New | +$2.49M | 0.1% | 357 |
|